[go: up one dir, main page]

MX9706565A - Estimulacion de meiosis. - Google Patents

Estimulacion de meiosis.

Info

Publication number
MX9706565A
MX9706565A MX9706565A MX9706565A MX9706565A MX 9706565 A MX9706565 A MX 9706565A MX 9706565 A MX9706565 A MX 9706565A MX 9706565 A MX9706565 A MX 9706565A MX 9706565 A MX9706565 A MX 9706565A
Authority
MX
Mexico
Prior art keywords
meiosis
stimulation
vivo
compounds
oocytes
Prior art date
Application number
MX9706565A
Other languages
English (en)
Other versions
MXPA97006565A (es
Inventor
Erling Guddal
Anne Grete Byskov
Frederik Christian Gronvald
Lars Nordholm
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX9706565A publication Critical patent/MX9706565A/es
Publication of MXPA97006565A publication Critical patent/MXPA97006565A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/061—Sperm cells, spermatogonia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion se refiere al uso de ciertos compuestos químicos que interfieren con la biosíntesis del colesterol, y medicamentos que comprenden tales compuestos, para la estimulacion de la meiosis de oocitos y células germinales masculinas in vivo, ex vivo e in vitro.
MXPA/A/1997/006565A 1995-03-06 1997-08-28 Estimulacion de meiosis MXPA97006565A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK23295 1995-03-06
DK0232/95 1995-03-06
DK30995 1995-03-24
DK0309/95 1995-03-24
PCT/DK1996/000093 WO1996027658A1 (en) 1995-03-06 1996-03-06 Stimulation of meiosis

Publications (2)

Publication Number Publication Date
MX9706565A true MX9706565A (es) 1997-11-29
MXPA97006565A MXPA97006565A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
US5830757A (en) 1998-11-03
KR19980702624A (ko) 1998-08-05
JPH11501806A (ja) 1999-02-16
AU4784596A (en) 1996-09-23
HUP9800731A2 (hu) 1998-07-28
NO974089L (no) 1997-09-05
HUP9800731A3 (en) 2000-03-28
EP0813595A1 (en) 1997-12-29
NO974089D0 (no) 1997-09-05
RU2188006C2 (ru) 2002-08-27
PL322106A1 (en) 1998-01-05
AU717180B2 (en) 2000-03-16
BR9607673A (pt) 1998-06-16
CZ279797A3 (cs) 1998-01-14
CA2214126A1 (en) 1996-09-12
WO1996027658A1 (en) 1996-09-12

Similar Documents

Publication Publication Date Title
AP1411A (en) Pyrrolo[2,3d] pyrimidine compositions and their use.
IL111734A0 (en) Compositions for the preparation of in vivo therapeutic products
NZ312665A (en) Rrolopyrimidines(7h-pyrrolo[2,3-d]pyrimidine and preparation of these
BG100293A (en) 2,8-disubstituted quinazolinons
HU9603584D0 (en) Sterol derivatives which applicable for regulation of meiosis
GB9813540D0 (en) Chemical compounds
ZA944347B (en) The use of cetrorelix and other nona- and decapeptides in the preparation of a medicament for combating aids and for growth stimulation
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
HUP9800731A2 (hu) Eljárás ivarsejt osztódás stimulálására
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
AU4268696A (en) Pyridine and pyrazinedicarboxylic-acid derivatives as cell proliferation regulators
AU5691796A (en) Terpenoidic derivatives useful as antitumor agents
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
WO2000042987A3 (en) Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
MX9803610A (es) Utilizacion de flupirtina para la profilaxis y la terapia de enfermedades que van a compañadas de un deterioro del sistema celular hermatopoyetico.
GB9505082D0 (en) Medicament
AU6877587A (en) Expellants of phytopathogenic microbes
GB9818445D0 (en) Medicaments
MD1119G2 (ro) Metodă de tratament al afecţiunilor inflamatorii ale organelor genitale feminine
AU3172600A (en) Use of vitamin c or the like for stimulating skin cell synthesis
AU1799097A (en) Presentation of antigen, introduced into the cells by stimulation of macropinocytosis
MX9803681A (es) Inhibicion de la expresion de membrana.
UA32241A (uk) Спосіб лікування запалювальних процесів у експериментальних тварин
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy